GHK-Cu is one of the most studied (and sometimes misunderstood) compounds in longevity research today.

GLP-1 medications entered the mainstream conversation through weight loss. But in academic medicine, GLP-1 signaling has been studied for years in the context of cardiovascular disease, kidney disease, fatty liver disease, and increasingly, neurodegeneration. Now a new question is emerging in longevity circles: What happens if we use very small doses—not for weight loss—but to support metabolic health as we age? This article isn’t about hype. It’s about biology, data, and careful...

If you’re in perimenopause or menopause, you’ve probably noticed your body changing in ways that feel completely out of your control. You might be eating the same things, training consistently, prioritizing movement, staying hydrated — and still watching body fat creep up, especially around your belly. It’s frustrating, and it’s not your fault . Those changes are driven by biology, not willpower. Here’s the good news: science is giving us new tools that actually address why these changes...